Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (accRCC): Results from cohort A of KEYNOTE-427

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 36; no. 15_suppl; p. 4500
Main Authors McDermott, David F., Lee, Jae-Lyun, Szczylik, Cezary, Donskov, Frede, Malik, Jahangeer, Alekseev, Boris Yakovlevich, Larkin, James M. G., Matveev, Vsevolod Borisovich, Gafanov, Rustem Airatovich, Tomczak, Piotr, Tykodi, Scott S., Geertsen, Poul F., Wiechno, Pawel J., Shin, Sang Joon, Pouliot, Frederic, Alonso Gordoa, Teresa, Li, Wenting, Perini, Rodolfo F., Schloss, Charles, Atkins, Michael B.
Format Journal Article
LanguageEnglish
Published 20.05.2018
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/JCO.2018.36.15_suppl.4500